IQVIA Holdings Inc. which can be found using ticker (IQV) now have 18 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 281 and 215 calculating the mean target price we have $249.39. Now with the previous closing price of $201.51 this indicates there is a potential upside of 23.8%. Also worth taking note is the 50 day moving average now sits at $211.60 and the 200 day MA is $209.92. The market cap for the company is 37.46B. The stock price for the company is currently is currently 204.56 USD
The potential market cap would be $46,360,024,933 based on the market consensus.
The company has a dividend yield of 2.93%. Other points of data to note are a P/E ratio of 35.09, revenue per share of 79.12 and a 4.79% return on assets.
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, providing outsourced clinical research and clinical trial related services. The Contract Sales & Medical Solutions segment provides health care provider, including contract sales and patient engagement services to both biopharmaceutical clients and the broader healthcare market. The Company protects individual patient privacy. The Company conducts business in more than 100 countries.
